[1] |
ZHANG B, ZHANG B, ZHANG Z, et al. 42 573 Cases of hepatectomy in China:a multicenter retrospective investigation[J]. Sci China Life Sci, 2018, 61(6):660-670.
DOI
URL
|
[2] |
GUO C, JU Q Q, ZHANG C X, et al. Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia[J]. BMC Cancer, 2020, 20(1):586.
DOI
URL
|
[3] |
ZHU C, SONG H, XU F, et al. Hepatitis B virus inhibits the expression of complement C3 and C4,in vitro and in vivo[J]. Oncol Lett, 2018, 15(5):7459-7463.
|
[4] |
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华肝脏病杂志, 2019, 27(12):938-961.
|
[5] |
LIU X, ZHU C, LI J, et al. HBV upregulates CtBP2 expression via the X gene[J]. Biomed Res Int, 2018, 2018:6960573.
|
[6] |
SONG C, HAN Y, LUO H, et al. HOXA10 induces BCL2 expression,inhibits apoptosis,and promotes cell proliferation in gastric cancer[J]. Cancer Med, 2019, 8(12):5651-5661.
DOI
URL
|
[7] |
KURSCHEID S, BADY P, SCIUSCIO D, et al. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma[J]. Genome Biol, 2015, 16(1):16.
DOI
URL
|
[8] |
TANG W, JIANG Y, MU X, et al. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression[J]. Cell Signal, 2014, 26(7):1420-1426.
DOI
URL
|
[9] |
CHATURVEDI V K, SINGH A, DUBEY S K, et al. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma[J]. Microb Pathog, 2019, 128:184-194.
DOI
URL
|
[10] |
JIA L, GAO Y, HE Y, et al. HBV induced hepatocellular carcinoma and related potential immunotherapy[J]. Pharmacol Res, 2020, 159:104992.
DOI
URL
|
[11] |
YANG Q, ZHANG Q, ZHANG X, et al. HoxA10 facilitates SHP-1-catalyzed dephosphorylation of p38 MAPK/STAT3 to repress hepatitis B virus replication by a feedback regulatory mechanism[J]. J Virol, 2019, 93(7):e01607-18.
|
[12] |
MAK L Y, WONG D K, POLLICINO T, et al. Occult hepatitis B infection and hepatocellular carcinoma:epidemiology,virology,hepatocarcinogenesis and clinical significance[J]. J Hepatol, 2020, 73(4):952-964.
DOI
URL
|
[13] |
WANG Q, CHENG S T, CHEN J. HBx mediated increase of SIRT1 contributes to HBV-related hepatocellular carcinoma tumorigenesis[J]. Int J Med Sci, 2020, 17(12):1783-1794.
DOI
URL
|
[14] |
XIE W H, DING J, XIE X X, et al. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation[J]. Inflamm Res, 2020, 69(7):683-696.
DOI
URL
|
[15] |
ZHU K, HUANG W, WANG W, et al. Up-regulation of S100A4 expression by HBx protein promotes proliferation of hepatocellular carcinoma cells and its correlation with clinical survival[J]. Gene, 2020, 49:144679.
|
[16] |
LI Y, WANG C, ZHAO T, et al. Hepatitis B virus X protein modulates chemokine CCL15 upregulation in hepatocellular carcinoma[J]. Anticancer Agents Med Chem, 2021. [Epub ahead of print]
|
[17] |
ZHANG Y, CHEN J, WU S S, et al. HOXA10 knockdown inhibits proliferation,induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells through HDAC1[J]. Cancer Manag Res, 2019, 11:7065-7076.
DOI
URL
|